Showing results (201-210 of 320) with videos related to

Sort By:
Pageof 32
Inorganic Chemistry Frontiers|January 13, 2025
A new fluorescent oxaliplatin(iv) complex with EGFR-inhibiting properties for the treatment of drug-resistant cancer cellsMonika Caban, Philipp Fronik, Alessio Terenzi, et al.
Cancer Letters|July 19, 2017
Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasisBeatrix Schoenhacker-Alte, Thomas Mohr, Christine Pirker, et al.
Inorganic Chemistry Frontiers|April 7, 2025
Albumin-targeted oxaliplatin(iv) prodrugs bearing STING agonistsMartijn Dijkstra, Michael Gutmann, Mathias Gradl, et al.
Molecular Cancer Therapeutics|October 15, 2008
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibitionHendrik Fischer, Ninon Taylor, Sigrid Allerstorfer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapyMir Alireza Hoda, Amir Mohamed, Bahil Ghanim, et al.
Cancer Research|April 6, 2006
Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERTAndreas Brachner, Soleman Sasgary, Christine Pirker, et al.
Toxins|August 25, 2017
The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot StudyDaniela Heilos, Yelko Rodríguez-Carrasco, Bernhard Englinger, et al.
Bioinorganic Chemistry and Applications|September 29, 2025
Exploring the Anticancer Properties of 4-Phenylthiazole-Based Ru(II) and Os(II) Metallacycles Featuring 1-Methylimidazole as <i>N</i>-Donor FunctionalityPaul Getreuer, Theresa Mendrina, Steven van Terwingen, et al.
Biochemical Pharmacology|December 14, 2005
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)Petra Heffeter, Michael A Jakupec, Wilfried Körner, et al.
International Journal of Cancer|November 5, 2016
The plasma membrane Ca<sup>2+</sup> pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cellsLuca Hegedũs, Tamás Garay, Eszter Molnár, et al.
Pageof 32